Broadcom Plunges, Petco Slides, UnitedHealth Rises as BofA Lifts to Buy on Improving Cost Trend

Broadcom Drops, CrowdStrike Falls, Five Below Tumbles After Beat as Retailer Frets Over Consumer

On this episode of Stock Movers: - Broadcom (AVGO) shares fall after the chipmaker gave an outlook that was seen as underwhelming given the industry’s AI-related demand. - CrowdStrike (CRWD) shares fall after the security software company reported first-quarter results beat, which wasn’t strong enough to lift the stock that has more than doubled from a March low. - Five Below (FIVE) shares fall after the retailer reported results, and while the quarter was a “standout,” the growth rate might be peaking, according to Jefferies. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Broadcom Plunges, Petco Slides, UnitedHealth Rises as BofA Lifts to Buy on Improving Cost Trend

On this episode of Stock Movers: -Broadcom (AVGO) shares plunged after the company’s forecast for sales of its artificial intelligence chips disappointed investors. AI semiconductor revenue will be $16 billion in the fiscal third quarter, falling well below analysts’ expectations of $17.2 billion on average. -Petco (WOOF) shares fell as much as 18% in postmarket trading after the company's second-quarter forecast fell below consensus estimates. The company reported adjusted Ebitda of $97.3 million and net sales rose 0.2% to $1.5 billion, the first year-over-year sales growth after five consecutive quarters of contraction. -UnitedHealth (UNH) shares rise. BofA Global Research upgraded the health insurer to buy from neutral, citing improving medical cost trends. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Petco Shares Drop; Five Below Shares Slide; Calvin Klein Owner PVH Sinks

Today's biggest winners and losers in the stock market. On this episode of Stock Movers:- Petco (WOOF) shares tumble after the pet health and wellness company’s adjusted Ebitda forecast for the second quarter came in below the average analyst estimate. - Five Below (FIVE) shares are down after the retailer reported results, and while the quarter was a “standout,” the growth rate might be peaking, according to Jefferies. Citi said the unchanged 2H26 guidance feeds into the bear case that comps will slow over next year. - PVH (PVH) shares tumble after reaffirmed adjusted earnings-per-share guidance from the owner of the Calvin Klein and Tommy Hilfiger brands missed consensus estimates. Analysts note sustained pressures from the Middle East conflict. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Broadcom Sinks After Disappointing Outlook; CrowdStrike Results Fail to Wow; Petco Shares Drop

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Broadcom (AVGO) shares fall after the chipmaker gave an outlook that was seen as underwhelming, given the industry’s AI-related demand. Analysts note that AI sales and margins for the current quarter are weaker than expected. - CrowdStrike (CRWD) shares are down after the security software company reported first-quarter results beat, which wasn’t strong enough to lift the stock that has more than doubled from a March low. - Petco (WOOF) shares tumble after the pet health and wellness company’s second-quarter adjusted Ebitda forecast came in below the average analyst estimate. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Remy Cointreau Rises, Abivax Gains, Universal Dips

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Remy Cointreau posted slightly better-than-expected annual profit as strong growth in the Americas helped the Cognac maker stem losses from tepid demand in its critical European and Chinese markets. - Abivax shares climb as much as 14% in Paris, extending a rally after the stock plunged due to cancer cases in a crucial clinical trial. The market reaction to the cases in the French biotech company’s late-stage trial results for its experimental ulcerative colitis drug are “overdone,” according to Stifel analysts. - Universal Music Group shares fell after Bill Ackman sold his €1.42 billion ($1.65 billion) stake in the Amsterdam-listed company just days after it rejected a takeover bid by the hedge fund billionaire. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.